The Rett Syndrome Research Trust (RSRT), the organization singularly focused on curing Rett syndrome, today announced 2025 research awards totaling $6.4 million, further advancing genetic medicine ...

Monster-taming action RPG Voidling Bound will launch for PC via Steam on June 9, followed by PlayStation 5, Xbox Series, and Switch 2 at a later date, developer Hatchery Games announced.

Del-desiran effectively delivered siRNA to muscle, resulting in approximately 40% mean reduction in DMPK mRNA and amelioration of missplicingTreatment ...

Del-desiran (also known as AOC1001) is an antibody-oligonucleotide conjugate comprised of a DMPK small interfering RNA (siRNA ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Retrotransposons are pivotal in human genome evolution, driving structural variation and regulatory innovation while influencing health and disease.

Machado-Joseph disease causes sufferers to struggle with speech and movement as they lose control of their bodies.

And the presence of the Barcelona Science Park, which is the first science park in Spain that is home to three research institutes and more than 70 companies, make the city a viable location for ...

ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...

Although the participation of spliceosomes is almost always required for intron removal, a few types of genes have self-splicing RNA introns.

ArgenTag have joined PacBio’s Compatible Partner Program and opened a grant to provide access to single-cell sequencing tech.

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.